Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- 5-Year Study Published In Diabetologia Demonstrated Long-Term Safety Of Lantus(R) Compared To NPH
- Safety And Cognitive Stability Are Key Findings In Phase IIA Trial Of New Alzheimer's Disease Treatment From Humanetics Corporation
- Designing A Risk Evaluation And Mitigation Strategies (REMS) System
- FDA Warns Drug Maker on Cold Medicines with Vitamin C
- E-Learning Opportunity To Specifically Focus On Trials Of Biologics
- Device Maker Recalls Insulin Infusion Sets
- Ipsen's Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint In The First Phase III Clinical Trial
- Poor Sensitivity Mars Rapid H1N1 Flu Testing (CME/CE)
- Team-Based Care Involving A Pharmacist Improves Blood Pressure Control
- Biomarkers Predict Brain Tumor's Response To Therapy
Pharmacy Bodies Call For Reinstatement Of Community Pharmacists To The Shortage Occupations List, UK
Posted by: admin in Pharmacy Drugs on July 25th, 2009
The CCA, AIMp, BPSA, and NPA are appealing for an immediate reinstatement of community pharmacists to the Shortage Occupations List after the removal of community pharmacists from the list by the Migration Advisory Committee (MAC) last month.
The pharmacy bodies have submitted evidence jointly to MAC of the shortage of community pharmacists and the need for non-EU pharmacists to be permitted to work in UK community pharmacy.
The evidence submitted includes workforce statistics that demonstrate the difficulty in assessing the number of pharmacists required from simply looking at the workforce census data. In addition the picture is not uniform across the country and several areas of the UK have particularly hard to fill vacancies.
There is an increased demand for community pharmacists due to the rise in pharmacy numbers throughout the United Kingdom (2008 to 2009), increasing opening hours and demand for pharmacists to deliver additional services.
The MAC decision has practical consequences for pharmacy businesses and human consequences. Amongst others, it affects non-EU overseas pharmacists in the UK who have just completed their diploma and who have had offers of pre-registration training jeopardised by the ruling. BPSA has submitted evidence of the hardship being caused to these students. The decision, if not reversed, will have a consequential impact of registrations in 2010.
The pharmacy bodies are asking for an urgent meeting with the MAC secretariat and officials from the UK Border Agency to argue for an immediate reinstatement of community pharmacies onto the Shortage Occupations List.
Source
National Pharmacy Association
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.